戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Beckwith-Wiedemann syndrome (BWS) is a clinically variab
2                                              Beckwith-Wiedemann syndrome (BWS) is a congenital cancer
3                                              Beckwith-Wiedemann syndrome (BWS) is a fetal overgrowth
4                                              Beckwith-Wiedemann syndrome (BWS) is a hereditary human
5                                              Beckwith-Wiedemann syndrome (BWS) is a human stem cell d
6                                              Beckwith-Wiedemann syndrome (BWS) is a model human impri
7                                              Beckwith-Wiedemann syndrome (BWS) is an autosomal domina
8                                              Beckwith-Wiedemann syndrome (BWS), which causes prenatal
9                                              Beckwith-Wiedemann syndrome (BWS), which predisposes to
10 ing guidelines for neurofibromatosis type 1, Beckwith-Wiedemann syndrome/ hemihypertrophy, and PTEN h
11 ted with the Prader-Willi Syndrome (PWS) and Beckwith-Wiedemann Syndrome (BWS) where imprinting is kn
12 line balanced chromosomal rearrangements and Beckwith-Wiedemann syndrome.
13       This locus is of specific interest, as Beckwith-Wiedemann syndrome and various childhood and ad
14 associated with imprinting disorders such as Beckwith-Wiedemann syndrome (BWS).
15 s region to growth-related disorders such as Beckwith-Wiedemann syndrome and a variety of human cance
16 to develop rare epigenetic disorders such as Beckwith-Wiedemann Syndrome or Angelman Syndrome, both o
17  diseases associated with imprinting such as Beckwith-Wiedemann syndrome.
18 them from the mutations of CDKN1C that cause Beckwith-Wiedemann syndrome, an overgrowth syndrome.
19 ergrowth and cancer predisposition condition Beckwith-Wiedemann syndrome (BWS).
20 1 that are associated with the human disease Beckwith-Wiedemann syndrome (BWS) may disrupt CDKN1C exp
21 nd genotypes characterize the human disease, Beckwith--Wiedemann syndrome (BWS).
22 s associated with the developmental disorder Beckwith Wiedemann Syndrome (BWS) and with several cance
23 ) we have found that the hereditary disorder Beckwith-Wiedemann syndrome, which predisposes to cancer
24 mprinting-related fetal overgrowth disorder, Beckwith-Wiedemann syndrome.
25 gene is associated with the growth disorders Beckwith-Wiedemann and Silver-Russell syndromes and many
26 sociated with the human imprinting disorders Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syn
27 on and the two contrasting growth disorders, Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syn
28 l group migration, similar to that in a Dowd-Beckwith ring expansion.
29          In these cases a fully equilibrated Beckwith-Houk-type transition state provides a satisfact
30 developing human brains and fibroblasts from Beckwith-Wiedemann syndrome patients.
31  lead to serious imprinting disorders (e.g., Beckwith-Wiedemann syndrome) and is described in some ca
32 mosome 11p15.1, centromeric to the imprinted Beckwith-Wiedemann syndrome (BWS) locus at 11p15.5.
33 of several pediatric and adult tumors and in Beckwith-Wiedemann syndrome (BWS).
34 ryonal tumors, including Wilms tumor, and in Beckwith-Wiedemann syndrome.
35 ome 11 at band p15.5, a region implicated in Beckwith-Wiedemann syndrome and a region of frequent los
36 s in human p57(Kip2) have been implicated in Beckwith-Wiedemann syndrome, a disease that has also bee
37 ed expression of IGF2 has been implicated in Beckwith-Wiedemann syndrome, a human fetal overgrowth sy
38 man chromosome 11p15.5, a region involved in Beckwith-Wiedemann syndrome, Wilms' tumor, and ovarian,
39 tes, a situation similar to that observed in Beckwith-Wiedemann syndrome, another imprinted disorder.
40 ncer and some hereditary diseases, including Beckwith-Wiedemann syndrome (BWS), a disorder of prenata
41          A related developmental disorder is Beckwith-Wiedemann syndrome (BWS), which increases risk
42 ted with a human overgrowth syndrome-namely, Beckwith-Wiedemann syndrome (BWS).
43  Igf2 overexpression as a key determinant of Beckwith-Wiedemann syndrome.
44 all report an unexpectedly high incidence of Beckwith-Wiedemann syndrome (BWS) in children conceived
45 he mouse which will lead to animal models of Beckwith-Wiedemann syndrome and childhood tumours.
46 , are both implicated in the pathogenesis of Beckwith-Wiedemann syndrome.
47 , with six patients not showing phenotype of Beckwith-Wiedemann syndrome.
48 n of Igf2 results in most of the symptoms of Beckwith-Wiedemann syndrome, including prenatal overgrow
49 umor suppression and the cancer-predisposing Beckwith-Wiedemann syndrome (BWS).
50 implicated in the development of tumor-prone Beckwith-Wiedemann syndrome, is an effector molecule of
51 imprinted status of the genes in the region, Beckwith-Wiedemann syndrome (BWS) and Wilms tumor are ea
52  during childhood, including retinoblastoma, Beckwith-Wiedemann syndrome/idiopathic hemihypertrophy a
53 roblasts derived from patients with sporadic Beckwith-Wiedemann syndrome (BWS), a fetal overgrowth sy
54 ype often associated with the human syndrome Beckwith-Wiedemann.
55 re likely to develop the overgrowth syndrome Beckwith-Wiedemann (BWS).
56 loss-of-imprinting (LOI) overgrowth syndrome Beckwith-Wiedemann (BWS).
57 und in the human foetal overgrowth syndrome, Beckwith-Wiedemann syndrome (BWS).
58                                          The Beckwith-Wiedemann syndrome (BWS) is genetically linked
59                                          The Beckwith-Wiedemann syndrome (BWS) is marked by fetal org
60                                          The Beckwith-Wiedemann syndrome is associated with the failu
61 ed groups, consistent with prediction by the Beckwith-Houk model for stereocontrol in 5-hexenyl radic
62 nkage analysis to harbor the gene(s) for the Beckwith-Wiedemann syndrome.
63 e p57(Kip2) locus has been implicated in the Beckwith-Wiedemann syndrome and in the development of sp
64 enal defects, which are also features of the Beckwith-Wiedemann syndrome (BWS), a genetically complex
65 ons affecting the WT1 gene or linkage to the Beckwith-Weidemann syndrome of the BWS region on the sho
66 ilms' tumors, and tumors associated with the Beckwith-Wiedemann syndrome.
67 H analysis to map the breakpoints from three Beckwith-Wiedemann syndrome patients and a rhabdoid tumo
68            Disruption of imprinting leads to Beckwith-Wiedemann syndrome (BWS), an overgrowth and can
69                 p57(Kip2) has been linked to Beckwith-Wiedemann syndrome and IMAGe syndrome in humans
70 imprinting region at 11p15.5 associated with Beckwith-Wiedemann syndrome.
71                                Children with Beckwith-Wiedemann syndrome (BWS) are at increased risk
72 uency of ART conceptions among children with Beckwith-Wiedemann syndrome or Angelman syndrome caused
73 ART was found in registries of children with Beckwith-Wiedemann syndrome, Angelman syndrome, and reti
74 n of human chromosome 11p15.5 is linked with Beckwith-Wiedemann syndrome that is associated with susc
75 rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS) have been mapped to 11
76 rearrangement breakpoints from patients with Beckwith-Wiedemann syndrome (BWS), a condition character
77  chromosomal rearrangements in patients with Beckwith-Wiedemann syndrome (BWS), which causes prenatal
78 he normal kidney and tongue of patients with Beckwith-Wiedemann syndrome (BWS), which predisposes to
79 their occasional occurrence in patients with Beckwith-Wiedemann syndrome and the case presented here
80 se phenotypes are also seen in patients with Beckwith-Wiedemann syndrome, a pleiotropic hereditary di

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。